三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

已收盘 12-05 16:09:08

29.580

-0.140

-0.47%

最高29.960	最低29.200	成交量919.31万
今开29.740	昨收29.720	日振幅2.56%
总市值719.68亿	流通市值719.68亿	总股本24.33亿
成交额2.72亿	换手率0.38%	流通股本24.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":29.58,"timestamp":1764922148004,"preClose":29.72,"halted":0,"volume":9193101,"delay":0,"floatShares":2433000000,"shares":2433000000,"eps":0.9500822896551724,"marketStatus":"已收盘","change":-0.14,"latestTime":"12-05 16:09:08","open":29.74,"high":29.96,"low":29.2,"amount":271589204,"amplitude":0.025572,"askPrice":29.6,"askSize":18000,"bidPrice":29.58,"bidSize":58500,"shortable":3,"etf":0,"ttmEps":1.056236667735658,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":29.72,"dividendRate":0.008742,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.388057,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU1251922891.USD","01099","BK1197","BK1500","LU0634319403.HKD","LU1969619763.USD","LU2476274720.SGD","01789","LU0640798160.USD","LU0348766576.USD","IE00BPRC5H50.USD","01530","LU0540923850.HKD","BK1588","LU2476274308.USD","LU0417516571.SGD","BK1585","LU0417516902.SGD","BK1593","BK1141","03329","IE00B5MMRT66.SGD","LU2488822045.USD","LU1303224171.USD","LU2328871848.SGD","09688","LU0348825331.USD","LU2778985437.USD","BK1617","BK1147","02228","BK1583","SG9999014674.SGD","LU2399975544.HKD","LU0417516738.SGD","03933","02367","LU0348827113.USD","02268","LU1794554557.SGD","BK1161","02196","SG9999004311.SGD","LU0588546209.SGD","LU1770034418.SGD","LU0561508036.HKD","06160","09926","HK0000165453.HKD"],"gpt_icon":0},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0188","BK0010","03329","BK1588","06996","BK0082","BK1161","600056","BK1141","BK1587","BK0250","BK1593","02096","BK1147","02268","SG9999014674.SGD","BK1583","BK1574","01530","BK0175","HK0000165453.HKD","BK0185","LU2488822045.USD","BK0028","00013"],"gpt_icon":0},{"id":"2589321578","title":"12月4日港股药品及生物科技行业沽空数据盘点，药明生物、三生制药、石药集团沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2589321578","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589321578?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:06","pubTimestamp":1764842782,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有79只被沽空，总沽空股数为9208.67万股，总沽空金额为16.44亿元（港元），而当日药品及生物科技行业的总成交金额为116.21亿元（港元），沽空比例为14.14%。从沽空金额来看，药明生物、三生制药、石药集团沽空金额位居行业前三，分别为2.23亿港元、2.03亿港元、1.53亿港元。沽空与卖空含义相同，即在并不持有股票的前提下，通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204181745a4cc6dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204181745a4cc6dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","IE00BZ08YS42.EUR","LU0417516902.SGD","LU1152091168.USD","LU1328277881.USD","LU1226287792.SGD","LU0326950275.SGD","LU1807302812.USD","LU0856984785.SGD","02269","LU1951186391.HKD","BK1589","LU0456846285.SGD","LU0181495838.USD","BK1161","SG9999004220.SGD","LU2039709279.SGD","LU1226287875.USD","LU0043850808.USD","LU0823426308.USD","LU0456827905.SGD","LU1242518931.SGD","01530","IE0008368742.USD","LU0359201612.USD","LU0140636845.USD","LU1880383366.USD","LU1688375341.USD","LU0516422952.EUR","LU0979878070.USD","LU3063872942.SGD","LU1794554557.SGD","LU0307460666.USD","IE00B5MMRT66.SGD","01093","BK1610","LU0819121731.USD","LU1813983027.USD","LU1226288170.HKD","LU0823426480.USD","LU0880133367.SGD","SG9999002463.SGD","LU1720050803.USD","LU0588546209.SGD","LU1242518857.USD","LU0516422440.USD","HK0000165453.HKD","BK1583","LU0320764599.SGD","LU0327786744.USD"],"gpt_icon":0},{"id":"2589983216","title":"每日卖空追踪 | 三生制药 12月04日卖空量成交307.45万股，卖空比例为15.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589983216?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837023,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月04日，涨1.43%，卖空量成交307.45万股，较上一交易日减少61.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163254a4cc36d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163254a4cc36d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"2589832154","title":"三生制药12月04日获主力加仓3988.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589832154","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589832154?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836142,"startTime":"0","endTime":"0","summary":"12月04日, 三生制药股价涨1.43%，报收29.72元，成交金额5.8亿元，换手率0.81%，振幅2.25%，量比0.88。三生制药今日主力资金净流入3988.7万元，连续3日净流入，上一交易日主力净流入4872.4万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为5.42%。该股近5个交易日下跌5.41%，主力资金累计净流入2.4亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入7.4亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161900a7234f3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161900a7234f3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","01530","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"2588003899","title":"12月3日港股药品及生物科技行业沽空数据盘点，三生制药、信达生物、百济神州沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2588003899","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588003899?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:06","pubTimestamp":1764756374,"startTime":"0","endTime":"0","summary":"当日药品及生物科技行业总体跌1.74%。从沽空金额来看，三生制药、信达生物、百济神州沽空金额位居行业前三，分别为2.37亿港元、1.53亿港元、9825.69万港元。从沽空比例偏离度来看，乐普生物-B、思派健康、信达生物沽空比例偏离度位居行业前三，分别为306.25%、195.17%、192.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120318154995289c94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120318154995289c94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","06160","BK1583","LU2097828714.EUR","LU2097828631.EUR","01530","LU0588546209.SGD","LU1719994722.HKD","LU2097828474.EUR","BK1588","LU2097828557.USD","LU1303224171.USD","LU0502904849.HKD","01801","BK1593","HK0000165453.HKD","BK1161","LU2488822045.USD","BK1500","LU2242644610.SGD","LU2097828805.USD","LU2328871848.SGD","LU1251922891.USD","LU1969619763.USD","LU1770034418.SGD","LU0455707207.USD","BK1589"],"gpt_icon":0},{"id":"1115519600","title":"三生制药（01530）11月股份变动月报表：已发行股本增至2,432,833,912股","url":"https://stock-news.laohu8.com/highlight/detail?id=1115519600","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115519600?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:36","pubTimestamp":1764750981,"startTime":"0","endTime":"0","summary":"2025年12月3日，三生制药发布2025年11月股份变动月报表。报告显示，公司于2025年11月30日的法定/注册股本仍为50,000,000,000股，面值0.00001美元，注册股本500,000美元，未有变动。截至2025年11月30日，公司已发行普通股由上月的2,432,593,912股小幅增至2,432,833,912股，新增240,000股，主要原因为根据公司股份期权计划行使购股权所致。公司声明已遵守香港联合交易所有限公司《上市规则》及相关法律规定，所有股份发行及期权行使均经董事会授权并合法合规执行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"gpt_icon":0},{"id":"2588674270","title":"智通港股沽空统计|12月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588674270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588674270?lang=zh_cn&edition=full","pubTime":"2025-12-03 08:20","pubTimestamp":1764721238,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，京东健康-R、京东集团-SWR、商汤-WR上一交易日沽空比率位于前三位，分别为100.00%、100.00%、80.34%。美团-W、腾讯控股、阿里巴巴-SW的沽空金额位居前三，分别为18.14 亿元、10.03 亿元、9.01 亿元。三生制药、OSL集团、京东集团-SWR的偏离值位居前三，分别为41.74%、36.46%、33.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03690","06808","MIUmain","002594","81211","01880","89618","HYDD.SI","01988","03143","03983","81024","HTCD.SI","LU2362541273.HKD","81810","BABA","LU0588545904.SGD","00347","00939","80992","GELYY","06618","80175","BYDDY","00863","METmain","ALBmain","00700","TCHmain","HXXD.SI","MPNGY","09988","89888","HMTD.SI","KSTmain","01530","EVS.SI","86618","80020","00020","00546","00175"],"gpt_icon":1},{"id":"2588325066","title":"每日卖空追踪 | 三生制药 12月02日卖空量成交1196.75万股，卖空比例为25.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588325066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588325066?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664220,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月02日，跌4.61%，卖空量成交1196.75万股，较上一交易日增加298.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163252952658a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163252952658a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","HK0000165453.HKD","01530","BK1583"],"gpt_icon":0},{"id":"1148400421","title":"港股创新药概念股午后持续走低，歌礼制药-B、三生制药跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148400421","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148400421?lang=zh_cn&edition=full","pubTime":"2025-12-02 13:12","pubTimestamp":1764652353,"startTime":"0","endTime":"0","summary":"12月2日，港股创新药概念股午后持续走低，$歌礼制药-B(01672)$、$三生制药(01530)$跌超5%，$先声药业(02096)$、$同源康医药-B(02410)$、$康诺亚-B(02162)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c54c8d8de852bbfb4567c558a904e399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","06978","BK1593","09939","02096","HK0000165453.HKD","01477","BK1515","02162","01672","BK1574","BK1583","BK1191","BK1587","02410","BK1161"],"gpt_icon":0},{"id":"2588406656","title":"三生制药盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588406656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588406656?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:30","pubTimestamp":1764639016,"startTime":"0","endTime":"0","summary":"2025年12月02日早盘09时30分，三生制药股票出现异动，股价快速下跌5.24%。三生制药股票所在的药品行业中，整体涨幅为0.08%。今年11月，三生制药宣布分拆旗下蔓迪国际，并向港交所递交招股书。正因如此，三生制药拆分蔓迪被投资者认为是剥离“核心资产”，11月21日消息公布当天，其股价下跌9.44%，收盘报29.34港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512020930199525aa27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512020930199525aa27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","HK0000165453.HKD","BK1161","01530"],"gpt_icon":0},{"id":"2588704525","title":"三生制药(01530)拟折让6.50%配股 净筹约30.87亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704525","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588704525?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:18","pubTimestamp":1764634707,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药 发布公告，于2025年12月2日，公司与独家配售代理订立配售协议，据此，公司已有条件同意透过独家配售代理按每股配售股份29.62港元的价格向不少于六名承配人配售合共1.05亿股配售股份。配售价为每股配售股份29.62港元。配售事项的估计所得款项总额及所得款项净额将分别约为31.15亿港元及30.87亿港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376299.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","HK0000165453.HKD","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2588091047","title":"智通港股早知道 | 2025脑机接口大会本周将在上海开幕 国际银价续创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2588091047","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588091047?lang=zh_cn&edition=full","pubTime":"2025-12-02 07:28","pubTimestamp":1764631696,"startTime":"0","endTime":"0","summary":"2025脑机接口大会本周将在上海开幕 将举办脑控实战竞赛记者从上海市科委举行的新闻通气会上获悉，2025脑机接口大会以“脑联世界、智汇上海”为主题，将于12月4日-5日在“脑智天地”集聚区举行。近日，该划转事项已获国务院国有资产监督管理委员会批准，后续将办理股份过户登记手续。五矿资源于2025年在High Lake及High Lake东部开展的资源扩展钻探也取得积极成果。光大证券发布研报称，矿端紧张传导至电解铜，继续看好铜价新高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06609","81211","00175","SG9999002224.SGD","601633","SG9999001424.SGD","LU1066051498.USD","LU1116320901.HKD","EVS.SI","002594","LU0345768740.USD","LU0588545490.SGD","BK1149","01208","82333","01530","LU1861214812.USD","LU1206712785.SGD","BYDDY","LU0157215616.USD","02333","IE0009356076.USD","LU0642271901.SGD","LU1244550221.USD","MACW.SI","LU0039217434.USD","06681","LU2242650005.HKD","LU2896262040.SGD","GWLLY","LU2065170008.USD","BK1132","00553","HYDD.SI","LU2168564149.EUR","SG9999014898.SGD","02172","BK1228","SG9999014542.SGD","LU0689626769.HKD","GELYY","LU0109391861.USD","80175"],"gpt_icon":1},{"id":"2586712332","title":"【券商聚焦】交银国际维持三生制药(01530)买入评级 指707海外开发快速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2586712332","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586712332?lang=zh_cn&edition=full","pubTime":"2025-11-28 09:32","pubTimestamp":1764293554,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，三生制药 合作伙伴大幅加速707海外临床开发：辉瑞近期披露SSGJ-707的开发计划，表示将围绕“速度、广度、深度”展开：1）在速度方面，辉瑞计划在近期快速启动至少7项临床试验，包括两项全球多中心III期临床，分别针对1L sq-/nsq-NSCLC和转移性结直肠癌，以及一项II/III期研究和四项I/II期研究。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970519","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"gpt_icon":0},{"id":"2586221909","title":"每日卖空追踪 | 三生制药 11月27日卖空量成交88.75万股，卖空比例为7.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586221909","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586221909?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232220,"startTime":"0","endTime":"0","summary":"三生制药北京时间11月27日，跌0.51%，卖空量成交88.75万股，较上一交易日减少72.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127163535951d57f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127163535951d57f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1583","BK1161","HK0000165453.HKD","BK1593"],"gpt_icon":0},{"id":"2586213491","title":"国泰海通证券：维持三生制药(01530)“增持”评级 分拆上市实现蔓迪加速发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213491","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213491?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:37","pubTimestamp":1764214648,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰海通证券发布研报称，上调三生制药目标价至47.84港元，维持“增持”评级，主要参考了公司基本面和PD1VEGF赛道巨大潜力，该行认为，三生制药分拆蔓迪国际独立上市，符合双方股东利益，三生制药余下业务更加专注创新药研发，蔓迪专注消费医疗产品布局。蔓迪积极拓展更广泛的皮肤健康及体重管理领域，通过持续商业化已上市产品及开发具潜力的管线资产满足中国快速发展的消费医疗市场日益增长的消费者需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","01530","02611"],"gpt_icon":0},{"id":"2586292126","title":"国信证券：维持三生制药(01530)“优于大市”评级 将开展两项关键3期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2586292126","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586292126?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:25","pubTimestamp":1764206753,"startTime":"0","endTime":"0","summary":"辉瑞公布707全球临床策略，第一波近期临床试验的核心为两项3期关键临床(NSCLC 1L;mCRC 1L)，并将于近期启动5项研究","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20251127/20251127092621_51620.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251127/20251127092621_51620.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01530","002736"],"gpt_icon":0},{"id":"2586648252","title":"三生制药：拟分拆蔓迪国际独立上市 拓展消费医疗业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2586648252","media":"中国财富通","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586648252?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:51","pubTimestamp":1764161476,"startTime":"0","endTime":"0","summary":"11月20日，三生制药宣布拟分拆旗下子公司蔓迪国际于港交所主板独立上市，港交所已确认可进行该分拆。分拆拟实物分派与全球发售结合根据三生制药发布的公告，此次分拆或将通过实物分派与全球发售相结合的方式进行。招股书显示，蔓迪国际2022年至2024年，蔓迪产品系列贡献了90%以上的收入。三生制药表示，蔓迪国际的独立上市，为公司旗下的消费医药业务板块树立了新的发展标杆，以更灵活的消费医药企业姿态迎接市场机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=hd8Pb%2FtgAII%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1583","159891","BK1161","BK1593","HK0000165453.HKD"],"gpt_icon":0},{"id":"2586256194","title":"汇添富基金增持三生制药(01530)116.2万股 每股作价约29.82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586256194","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586256194?lang=zh_cn&edition=full","pubTime":"2025-11-26 19:04","pubTimestamp":1764155040,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月21日，汇添富基金增持三生制药(01530)116.2万股，每股作价29.8174港元，总金额约为3464.78万港元。增持后最新持股数目约为1.46亿股，最新持股比例6.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","HK0000165453.HKD","BK1593","01530"],"gpt_icon":0},{"id":"1199345206","title":"港股异动 | 创新药概念股走高，三生制药涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199345206","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199345206?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:49","pubTimestamp":1764121793,"startTime":"0","endTime":"0","summary":"11月26日，港股创新药概念股走高，$三生制药(01530)$涨超6%，$石药集团(01093)$涨超5%，$歌礼制药-B(01672)$涨超4%，$康诺亚(02162)$、$信达生物(01801)$、$恒瑞医药(01276$、$康方生物(09926)$跟涨。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f33137255a9939753c52f207c24a91b1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","01672","01530","02162"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0541},{"period":"1month","weight":-0.0067},{"period":"3month","weight":-0.1666},{"period":"6month","weight":0.4831},{"period":"1year","weight":3.7182},{"period":"ytd","weight":3.9271}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003687},{"month":2,"riseRate":0.5,"avgChangeRate":0.007795},{"month":3,"riseRate":0.8,"avgChangeRate":0.121345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.029212}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}